These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 18655474
1. [The role of major vessels remodeling in development of left ventricular hypertrophy in patients with a predialysis stage of chronic renal failure]. Kutyrina IM, Rudenko TE, Shvetsov MIu, Kushnir VV. Ter Arkh; 2008; 80(6):37-41. PubMed ID: 18655474 [Abstract] [Full Text] [Related]
2. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney]. Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND. Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964 [Abstract] [Full Text] [Related]
3. [Factors influencing the condition of the intima-media complex of carotid and femoral arteries at initial stages of chronic renal failure]. Rudenko TE, Kutyrina IM, Kushnir VV, Shvetsov MIu. Ter Arkh; 2005; 77(6):46-50. PubMed ID: 16078600 [Abstract] [Full Text] [Related]
4. [Heart remodeling in patients with predialysis phase of chronic renal failure]. Shutov AM, Kondrat'eva NI, Kulikova ES, Ivashkina TN, Tomnikovskaia VS, Shepeleva GI. Ter Arkh; 2000; 72(6):46-9. PubMed ID: 10900649 [Abstract] [Full Text] [Related]
5. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease]. Rudenko TE, Kutyrina IM, Shvetsov MIu. Ter Arkh; 2012; 84(6):21-6. PubMed ID: 22997913 [Abstract] [Full Text] [Related]
6. [Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end-stage renal failure: impact of long-term erythropoietin therapy]. Dzgoeva FU, Gatagonova TM, Kadzaeva ZK, Khamitsaeva OV, Kochisova ZKh, Dzueva AT, Bazaeva BG, Bestaeva TL. Ter Arkh; 2013; 85(6):44-50. PubMed ID: 23866598 [Abstract] [Full Text] [Related]
7. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Greaves SC, Gamble GD, Collins JF, Whalley GA, Sharpe DN. Am J Kidney Dis; 1994 Nov; 24(5):768-76. PubMed ID: 7977318 [Abstract] [Full Text] [Related]
8. [Risk factors of vascular complications in patients at a predialysis stage of chronic renal failure]. Kutyrina IM, Rudenko TE, Shvetsov MIu, Kushnir VV. Ter Arkh; 2006 Nov; 78(5):45-50. PubMed ID: 16889049 [Abstract] [Full Text] [Related]
9. [Effects of arterial compliance on geometry of the left ventricle in patients with pre-dialysis chronic renal failure]. Shutov AM, Kulikova ES, Kondrat'eva NI, Ivashkina TN. Klin Med (Mosk); 2001 Nov; 79(11):36-9. PubMed ID: 11811106 [Abstract] [Full Text] [Related]
10. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients. Unver S, Kavlak E, Gümüsel HK, Celikbilek F, Esertas K, Muftuoglu T, Kirilmaz A. Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798 [Abstract] [Full Text] [Related]
11. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Woodiwiss AJ, Libhaber CD, Majane OH, Libhaber E, Maseko M, Norton GR. Am J Hypertens; 2008 Oct; 21(10):1144-51. PubMed ID: 18756261 [Abstract] [Full Text] [Related]
12. Patterns of left ventricular hypertrophy in chronic kidney disease: an echocardiographic evaluation. Sambi RS, Gaur AK, Hotchandani R, Aggarwal KK, Kaur S, Gupta M, Jain S, Krishna CK, Chopra HK, Anand V, Srivastava S, Gupta R, Parashar SK. Indian Heart J; 2011 Oct; 63(3):259-68. PubMed ID: 22734347 [Abstract] [Full Text] [Related]
13. [Calcification of peripheral arteries in patients with terminal renal failure on programmed hemodialysis]. Dzitoeva MIu, Milovanov IuS, Shilov EM, Safonov VV, Milovanova LIu, Kushnir VV. Ter Arkh; 2005 Oct; 77(6):50-4. PubMed ID: 16078601 [Abstract] [Full Text] [Related]
14. Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1-3. Pluta A, Stróżecki P, Krintus M, Odrowąż-Sypniewska G, Manitius J. Ren Fail; 2015 Aug; 37(7):1105-10. PubMed ID: 26156686 [Abstract] [Full Text] [Related]
15. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters. Kirkpantur A, Kahraman S, Yilmaz R, Arici M, Altun B, Erdem Y, Yasavul U, Turgan C. Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652 [Abstract] [Full Text] [Related]
16. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS). Cuspidi C, Mancia G, Ambrosioni E, Pessina A, Trimarco B, Zanchetti A, APROS Investigators. J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833 [Abstract] [Full Text] [Related]
17. Prevalence and patterns of left ventricular hypertrophy in patients with predialysis chronic renal failure. Ha SK, Park HS, Kim SJ, Park CH, Kim DS, Kim HS. J Korean Med Sci; 1998 Oct; 13(5):488-94. PubMed ID: 9811177 [Abstract] [Full Text] [Related]
18. Cardiac and arterial interactions in end-stage renal disease. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F. Kidney Int; 1996 Aug; 50(2):600-8. PubMed ID: 8840292 [Abstract] [Full Text] [Related]
19. Left ventricular hypertrophy in nondiabetic predialysis CKD. Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G. Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052 [Abstract] [Full Text] [Related]
20. Gender differences in mediators of left ventricular hypertrophy in dialysis patients. Savage T, Giles M, Tomson CV, Raine AE. Clin Nephrol; 1998 Feb; 49(2):107-12. PubMed ID: 9524781 [Abstract] [Full Text] [Related] Page: [Next] [New Search]